Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977; 70(Suppl 3): 140–141.
PMCID: PMC1543572

The influence of drug therapy on serum immunoglobulin profiles in rheumatoid arthritis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (258K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bluestone R, Goldberg LS. Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis. 1973 Jan;32(1):50–52. [PMC free article] [PubMed]
  • Farr M, Kendall MJ, Young DW, Meynell MJ, Hawkins CF. Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis. Ann Rheum Dis. 1976 Apr;35(2):163–167. [PMC free article] [PubMed]
  • ROPES MW, BENNETT GA, COBB S, JACOX R, JESSAR RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed]
  • Veys EM, Claessens HE. Serum levels of IgG, IgM, and IgA in rheumatoid arthritis. Ann Rheum Dis. 1968 Sep;27(5):431–440. [PMC free article] [PubMed]
  • Zuckner J, Ramsey RH, Dorner RW, Gantner GE., Jr Penicillamine in rheumatoid arthritis. Arthritis Rheum. 1970 Mar-Apr;13(2):131–138. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press